top of page

Future Events

  • CNM-Au8 Long-term Evidence and EAP Program Update
    CNM-Au8 Long-term Evidence and EAP Program Update
    CNM-Au8 Long-term Evidence and EAP Program Update
    Wed, Dec 04
    Virtual Zoom Event
    Dec 04, 2024, 7:00 PM EST
    Virtual Zoom Event
    Dec 04, 2024, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research.
  • Caring for ALS patients and ALS patients with Cognitive Difficulties
    Caring for ALS patients and ALS patients with Cognitive Difficulties
    Caring for ALS patients and ALS patients with Cognitive Difficulties
    Wed, Dec 18
    Virtual Zoom Event
    Dec 18, 2024, 7:00 PM EST
    Virtual Zoom Event
    Dec 18, 2024, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research.
  • Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Wed, Jan 08
    Virtual Zoom Event
    Jan 08, 2025, 7:00 PM EST
    Virtual Zoom Event
    Jan 08, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • ALS Studies, Trials, and Treatments with Dr. Molly Gale Hammell
    ALS Studies, Trials, and Treatments with Dr. Molly Gale Hammell
    ALS Studies, Trials, and Treatments with Dr. Molly Gale Hammell
    Wed, Jan 22
    Virtual Zoom Event
    Jan 22, 2025, 7:00 PM EST
    Virtual Zoom Event
    Jan 22, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • ALS Studies, Trials, and Treatments - AMP ALS
    ALS Studies, Trials, and Treatments - AMP ALS
    ALS Studies, Trials, and Treatments - AMP ALS
    Wed, Feb 05
    Virtual Zoom Event
    Feb 05, 2025, 7:00 PM EST
    Virtual Zoom Event
    Feb 05, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    Wed, Feb 19
    Virtual Zoom Event
    Feb 19, 2025, 7:00 PM EST
    Virtual Zoom Event
    Feb 19, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
bottom of page